137 related articles for article (PubMed ID: 3332090)
21. T-cell chronic lymphocytic leukaemia: anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2'-deoxycoformycin).
Spiers AS; Davis MP; Levine M; Li CY; Mangan KF; Mazza JJ; Neu LT; O'Brien J; Rauch AE; Wiltsie JC
Scand J Haematol; 1985 Jan; 34(1):57-67. PubMed ID: 2578689
[TBL] [Abstract][Full Text] [Related]
22. Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma.
Lembersky BC; Ratain MJ; Westbrook C; Golomb HM
Am J Hematol; 1988 Jan; 27(1):60-2. PubMed ID: 3128105
[TBL] [Abstract][Full Text] [Related]
23. Low-dose deoxycoformycin in lymphoid malignancy.
Grever MR; Leiby JM; Kraut EH; Wilson HE; Neidhart JA; Wall RL; Balcerzak SP
J Clin Oncol; 1985 Sep; 3(9):1196-201. PubMed ID: 2993534
[TBL] [Abstract][Full Text] [Related]
24. 2'-deoxycoformycin. A new anticancer agent.
Poster DS; Penta JS; Bruno S; Macdonald JS
Cancer Clin Trials; 1981; 4(2):209-13. PubMed ID: 7018725
[TBL] [Abstract][Full Text] [Related]
25. Alterations in erythrocyte adenine nucleotide pools resulting from 2'-deoxycoformycin therapy.
Koller CA; Mitchell BS
Cancer Res; 1983 Mar; 43(3):1409-14. PubMed ID: 6600652
[TBL] [Abstract][Full Text] [Related]
26. Response to deoxycoformycin in T cell leukaemias.
Catovsky D; Dearden C
Br Med J (Clin Res Ed); 1988 Jan; 296(6618):356. PubMed ID: 2894233
[No Abstract] [Full Text] [Related]
27. An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma.
Grever MR; Bisaccia E; Scarborough DA; Metz EN; Neidhart JA
Blood; 1983 Feb; 61(2):279-82. PubMed ID: 6600401
[TBL] [Abstract][Full Text] [Related]
28. Hypersensitivity reactions to deoxycoformycin.
O'Dwyer PJ; King SA; Eisenhauer E; Grem JL; Hoth DF
Cancer Chemother Pharmacol; 1989; 23(3):173-5. PubMed ID: 2784360
[TBL] [Abstract][Full Text] [Related]
29. What is the choice of treatment for hairy cell leukemia?
Golomb HM; Ratain MJ; Moormeier J
J Clin Oncol; 1989 Feb; 7(2):156-8. PubMed ID: 2783730
[No Abstract] [Full Text] [Related]
30. The treatment of hairy cell leukemia with 2'-deoxycoformycin: results in India and in the United States.
Spiers AS; Parekh SJ
Leukemia; 1987 Apr; 1(4):347-50. PubMed ID: 3499541
[TBL] [Abstract][Full Text] [Related]
31. Clinical consequences of 2'-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia.
Yamaguchi K; Yul LS; Oda T; Maeda Y; Ishii M; Fujita K; Kagiyama S; Nagai K; Suzuki H; Takatsuki K
Leuk Res; 1986; 10(8):989-93. PubMed ID: 3489140
[TBL] [Abstract][Full Text] [Related]
32. The activity of deoxycoformycin (pentostatin) in refractory leukemias and lymphomas.
Spiers AS
Ann N Y Acad Sci; 1985; 451():138-41. PubMed ID: 3878115
[No Abstract] [Full Text] [Related]
33. Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: a Pediatric Oncology Group Study.
Winick N; Buchanan GR; Murphy SB; Yu A; Boyett J
Med Pediatr Oncol; 1988; 16(5):327-32. PubMed ID: 3263563
[TBL] [Abstract][Full Text] [Related]
34. Response to deoxycoformycin in mature T cell malignancies.
Ho AD; Stryckmans P; Zittoun R
Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1483-4. PubMed ID: 3500754
[No Abstract] [Full Text] [Related]
35. Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia.
Plunkett W; Nowak B; Feun LG; Benjamin RS; Keating M; Freirich EJ
Adv Exp Med Biol; 1984; 165 Pt B():345-50. PubMed ID: 6372382
[No Abstract] [Full Text] [Related]
36. Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia.
Daenen S; Rojer RA; Smit JW; Halie MR; Nieweg HO
Br J Haematol; 1984 Dec; 58(4):723-7. PubMed ID: 6097297
[TBL] [Abstract][Full Text] [Related]
37. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Mitchell BS; Koller CA; Kelley WN
Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
[No Abstract] [Full Text] [Related]
38. Complete remission in hairy cell leukaemia achieved with pentostatin.
Spiers AS; Parekh SJ
Lancet; 1984 May; 1(8385):1080-1. PubMed ID: 6144012
[No Abstract] [Full Text] [Related]
39. The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy.
Grever MR; Siaw MF; Jacob WF; Neidhart JA; Miser JS; Coleman MS; Hutton JJ; Balcerzak SP
Blood; 1981 Mar; 57(3):406-17. PubMed ID: 6970050
[TBL] [Abstract][Full Text] [Related]
40. Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists.
Camisa C; Grever MR; Bouroncle B
J Am Acad Dermatol; 1985 Jun; 12(6):1108-9. PubMed ID: 3874216
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
